Tango Therapeutics (TNGX) Amortizatization of Intangibles (2023 - 2026)
Tango Therapeutics' (TNGX) quarterly Amortizatization of Intangibles came in at -$1.1 million in Q1 2026, down 76.18% year-on-year from -$4.7 million in Q1 2025, and down 46.35% quarter-over-quarter from -$768000.0 in Q4 2025.
Tango Therapeutics (TNGX) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends
Tango Therapeutics' Amortizatization of Intangibles history runs 4 years deep, the most recent figure standing at -$1.1 million for Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 76.18% year-over-year to -$1.1 million in Q1 2026; TTM through Mar 2026 was -$3.2 million, a 18.28% increase from a year earlier, with the FY2025 full-year figure at -$2.7 million, up 41.78% from the prior year.
- Amortizatization of Intangibles retreated to -$1.1 million in Q1 2026 per TNGX's latest filing, from -$768000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $739000.0 in Q3 2023 and bottomed at -$2.4 million in Q4 2023.
- The 4-year median for Amortizatization of Intangibles is -$876000.0 (2023), against an average of -$909461.5.
- Biggest YoY gain for Amortizatization of Intangibles was 63.79% in 2024; the steepest drop was 260.49% in 2024.
- Year by year, Amortizatization of Intangibles stood at -$2.4 million in 2023, then jumped by 63.79% to -$856000.0 in 2024, then advanced by 10.28% to -$768000.0 in 2025, then tumbled by 46.35% to -$1.1 million in 2026.
- Per Business Quant, the three latest TNGX Amortizatization of Intangibles figures stand at -$1.1 million (Q1 2026), -$768000.0 (Q4 2025), and -$560000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Tango Therapeutics | 3.86 Bn | 3.70 Bn | - | -1.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.12 Mn |
| Mar 31, 2026 | -1.12 Mn |
| Dec 31, 2025 | -768,000.00 |
| Dec 31, 2025 | -768,000.00 |
| Sep 30, 2025 | -560,000.00 |
| Sep 30, 2025 | -560,000.00 |
| Jun 30, 2025 | -722,000.00 |
| Jun 30, 2025 | -722,000.00 |
| Mar 31, 2025 | -638,000.00 |
| Mar 31, 2025 | -638,000.00 |
| Dec 31, 2024 | -856,000.00 |
| Dec 31, 2024 | -856,000.00 |
| Sep 30, 2024 | -1.19 Mn |
| Sep 30, 2024 | -1.19 Mn |
| Jun 30, 2024 | -1.20 Mn |
| Jun 30, 2024 | -1.20 Mn |
| Mar 31, 2024 | -1.37 Mn |
| Mar 31, 2024 | -1.37 Mn |
| Dec 31, 2023 | -2.36 Mn |
| Dec 31, 2023 | -2.36 Mn |